Concepts and challenges of biosimilars to mitigate the oncology drug expenses
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.
Autor principal: | Tania, Umme |
---|---|
Outros Autores: | Haque , Md. Aminul |
Formato: | Tese |
Idioma: | en_US |
Publicado em: |
Brac University
2021
|
Assuntos: | |
Acesso em linha: | http://hdl.handle.net/10361/15111 |
Registros relacionados
-
Biosimilar in lymphoma treatment
por: Tanisha, Mehrin Haque
Publicado em: (2021) -
Biosimilar insulins: a potential option in the treatment of Diabetes
por: Tabassum, Turana
Publicado em: (2022) -
Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
por: Tania, Umme
Publicado em: (2023) -
Advancement of Antibody-Drug conjugates in cancer treatment: A review
por: Sagar, Baejid Hossain
Publicado em: (2022) -
Immunotherapeutic approaches to treat cancer: Prospects and challenges
por: Fred, Namanda Rogers
Publicado em: (2021)